WORLD Johnson & Johnson suspends COVID-19 vaccine trials in Brazil

WORLD

Johnson & Johnson suspends COVID-19 vaccine trials in Brazil

Xinhua

07:38, October 14, 2020



File photo: AP

BRASILIA, Oct. 13 (Xinhua) -- The Janssen-Cilag company, the pharmaceutical division of U.S. multinational Johnson & Johnson, temporarily suspended clinical trials in Brazil of a vaccine against the novel coronavirus (COVID-19), the national health regulatory body Brazilian Health Surveillance Agency (Anvisa) said on Tuesday.

Janssen-Cilag notified Anvisa that testing to determine the safety and efficacy of its vaccine VAC31518COV3001 "was temporarily suspended due to a serious adverse occurrence in a volunteer abroad."

The company did not provide more details about the case, as the volunteer's health status is kept confidential.

According to Anvisa, the trials will not resume until there is an investigation into the cause of the problem by the Independent Safety Committee, as part of good clinical practice procedures.

"In Brazil, the inclusion of the first volunteer in the study occurred on Oct. 9 and new inclusions can only occur when there is authorization from Anvisa, which will proceed with the analysis of the research data and decide on the continuity or permanent suspension based on the safety and risk/benefit assessment," the agency said.

Janssen-Cilag received authorization from Anvisa in August to carry out the trials in Brazil.


Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue